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We report here an automated method for the identification of N-oxide functional groups in
drug metabolites by using the combination of liquid chromatography/tandemmass spectrom-
etry (LC/MSn) based on ion-molecule reactions and collision-activated dissociation (CAD).
Data-dependent acquisition, which has been readily utilized for metabolite characterization
using CAD-based methods, is adapted for use with ion-molecule reaction-based tandem mass
spectrometry by careful choice of select experimental parameters. Two different experiments
utilizing ion-molecule reactions are demonstrated, data-dependent neutral gain MS3 and
data-dependent neutral gain pseudo-MS3, both of which generate functional group selective
mass spectral data in a single experiment and facilitate increased throughput in structural
elucidation of unknown mixture components. Initial results have been generated by using an
LC/MSnmethod based on ion-molecule reactions developed earlier for the identification of the
N-oxide functional group in pharmaceutical samples, a notoriously difficult functional group
to identify via CAD alone. Since commercial software and straightforward, external instru-
ment modification are used, these experiments are readily adaptable to the industrial
pharmaceutical laboratory. (J Am Soc Mass Spectrom 2010, 21, 559–563) © 2010 American
Society for Mass SpectrometryThe identification of metabolites is a critical andchallenging task in the drug discovery and devel-opment process [1]. Liquid chromatography/tan-
dem mass spectrometry (LC/MSn) based on collision-
activated dissociation (CAD) has become the technique
of choice for structural elucidation of metabolites [2, 3].
Generally, the LC/MSn run is preceded by an initial
LC/MS experiment to identify the metabolites of inter-
est. These analytes are then targeted for subsequent
MSn by the user. However, in some cases, even after
several chromatographic runs, the structures of the
metabolites of interest may only be narrowed down to
a list of several possibilities. Thus, especially with the
need to unambiguously identify metabolites at early
stages of drug discovery, new, efficient, and more
structurally informative MSn methods are desired.
The development of data-dependent analysis meth-
ods has greatly expedited the process of structural
elucidation by increasing the amount of mass spectral
data acquired per chromatographic run. In these exper-
iments, software-based decision-making algorithms sig-
nal the mass spectrometer to perform MS2 and subse-
quent MSn experiments for ions detected in the initial
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specific set of user-defined criteria [4, 5]. In contrast to
analyte-targeted MSn scans, data-dependent scans al-
low all components of a complex mixture to be interro-
gated “on-the-fly,” requiring little to no prior knowl-
edge of the components present. Many examples can be
found in the literature that demonstrate the effect-
iveness of combining LC/MSn based on CAD with
data-dependent acquisition for rapid drug metabolite
characterization [6–11].
We recently reported an LC/MSn method based on
ion-molecule reactions followed by CAD for the iden-
tification of the N-oxide functional group in drug
metabolites [12]. This experiment used the neutral re-
agent tri(dimethylamino)borane (TDMAB) to rapidly
derivatize N-oxide containing protonated analytes that
were then further characterized by their unique frag-
mentation pattern upon collisional activation. This pa-
per demonstrated the utility of combining ion-molecule
reactions and CAD for identifying N-oxide drug metab-
olites, which are difficult to identify by CAD alone.
Here, we present a specific application of this method-
ology, which takes advantage of the data-dependent
scanning features available on many commercial mass
spectrometers to automate functional group identifica-
tion and increase throughput in structural elucidation
studies. We believe that this work represents the first
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data-dependent manner and, hence, emphasizes the
value of ion-molecule reactions as a complement to
CAD for the characterization of certain metabolites.
Experimental
The experiments were performed in a modified linear
quadrupole ion trap (LQIT) mass spectrometer (LTQ,
Thermo Scientific, San Jose, CA, USA) equipped with
an electrospray ionization (ESI) source and coupled to a
HPLC system (Surveyor, Thermo Scientific). Clozapine,
clozapine N-oxide, and TDMAB were acquired from
Sigma-Aldrich (St. Louis, MO, USA), hydroxylorata-
dine was acquired from Toronto Research Chemicals
(Toronto, ON, Canada), loratadine N-oxide was synthe-
sized [12], and olanzapine and olanzapine N-oxide
were provided by Eli Lilly and Co. (Indianapolis, IN,
USA). Sample solutions were prepared at various con-
centrations (109 to 106 M) in a 50/50 (vol/vol)
mixture of H2O and CH3OH. The analytes were sepa-
rated by reversed-phase HPLC and ionized via ESI by
using conditions described elsewhere [12]. Xcalibur
2.0 software was used for both data acquisition and
processing.
LC/MSn experiments were carried out by using the
data-dependent feature of Xcalibur 2.0, via the regime
depicted in Figure 1. The most abundant ion in the full
MS scan was isolated automatically (isolation width 2
Th; q value 0.25) and allowed to react (30 ms) with
TDMAB (introduced into the helium bath gas via an
external manifold, as described previously [13]). If the
desired reaction product (neutral gain of 98 Da) was
observed among the three most abundant peaks in the
MS2 scan, it was automatically isolated (isolation width
5 Th; q value 0.15–0.25) and subjected to CAD. CAD
involved application of an appropriate activation volt-
age (generally 10%–20% of the normalized collision
energy [14] for the analyte) for 30 ms in the presence of
helium. Following the acquisition of a CAD (MS3)
spectrum, the instrument automatically advanced to the
next full scan. If the desired ion-molecule reaction
product was not detected in the above experiment (MS2
scan), the instrument also advanced to the next full MS
scan. This cycle was repeated until completion of the
experiment. At the conclusion of the experiment, the
MS3 spectra were inspected by the user for the presence
of diagnostic fragment ions [12], which further confirm
the presence of the N-oxide functional group and
provide additional structural information.
Although most of the instrument settings for the
above data-dependent experiment are similar to those
typically employed, it is necessary to note a few impor-
tant exceptions. The first (and perhaps obvious) excep-
tion is that a negative number is entered in the neutral
loss trigger box, thus signaling a neutral gain experi-
ment. Second, the charge state of ions for the activation
event must be set to 2, even though most small
molecule analyses, such as this, focus on singly-chargedions. This is because the upper limit of the mass range
(actually the highest m/z value detected) for singly-
charged ions in data-dependent experiments is auto-
matically set to only 10% higher than the m/z value of
isolated ion, in the interest of maintaining a fast duty
cycle. Under these conditions, the reaction product ions
of most ion-molecule reactions (e.g., the product ions
formed in the reactions of interest here) are not de-
tected. However, when the ion charge state is set to 2,
the instrument will set the high mass limit to approxi-
mately twice that of the m/z value of isolated ion, in
anticipation of the formation of singly-charged frag-
ment ions (some of which may have an m/z value up to
twice that of the isolated ion) upon CAD. Finally,
although not the case for this experiment, ion-molecule
reactions that require reaction times longer than the typi-
cal 30 ms allotted for MS2 experiments (under “activation
time”) necessitate a shorter ion injection time or less signal
averaging per data-dependent experiment [5].
To examine whether the time of the duty cycle of the
Figure 1. Flow chart depicting the data-dependent strategy for
identifying N-oxide containing drug metabolites. This process can
be adapted for a variety of functional group selective ion-molecule
reactions by identification of the relevant neutral gain and deter-
mination of the diagnostic fragmentation pattern(s).above data-dependent experiments can be decreased,
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ments by subjecting the ion-molecule reaction product
ions formed in the trap to CAD without isolation
(pseudo-MS3) [15]. In a pseudo-MS3 experiment, a pre-
cursor ion (the protonated analyte) is isolated (isolation
width 2 Th; q value 0.15) and subjected to CAD (typical
normalized collision energy of 10%–15%) in the pres-
ence of TDMAB (MS2), which will produce both ion-
molecule reaction products and fragment ions. Rather
than isolating any ion-molecule reaction product ions
for CAD (conventional MS3), pseudo-MS3 was per-
formed by setting the instrument to activate ion-molecule
reaction product ions corresponding to a neutral gain of
98 Da (at the same normalized collision energy as MS2)
in the presence of all ions in the trap. Removal of the
isolation step allows the time of the duty cycle of the
MS3 experiment to be decreased; however, the trade-off
is that activation must be applied to the precursor ion
during the ion-molecule reactions due to software lim-
itations. Thus, the spectra obtained from this experi-
ment represent a composite of three separate MS exper-
iments: CAD of the protonated analyte (MS2), ion-
molecule reaction of the protonated analyte (MS2), and
CAD of the desired ion-molecule reaction product of
the protonated analyte (MS3). It should be noted that
this same approach would most likely be used to enact
this MS3 experiment on a triple quadrupole instrument.
Results and Discussion
Data-Dependent Neutral Gain MS3
A mixture of the antipsychotic drug clozapine and its
N-oxide metabolite was initially examined to demon-
strate the feasibility of combining data-dependent ac-
quisition with MS3 using functional group-selective
ion-molecule reactions followed by CAD in the LQIT on
the chromatographic time scale. The concentration of
clozapine N-oxide (1 g/mL) in the mixture was1%
(wt/wt) that of the endogenous drug clozapine, to
mimic situations that may be encountered in the phar-
maceutical setting. As the drug eluted from the column,
it was ionized by ESI and mass analyzed (MS survey
scan), after which the protonated molecule (the most
abundant ion) was automatically isolated and exposed
to TDMAB for 30 ms (MS2). Since the targeted neutral
gain (98 Da) was not observed, the instrument automat-
ically skipped the MS3 scan and instead progressed to
the next survey MS scan. Similarly, as the N-oxide
eluted from the column, it was ionized by ESI and mass
analyzed, and then the protonated molecule (m/z 343)
was isolated and exposed to TDMAB for 30 ms (MS2;
Figure 2). However, in this case, the diagnostic ion-
molecule reaction product (i.e., MH  TDMAB 
HN(CH3)2) was detected at m/z 441. Thus, this ion was
isolated and subjected to CAD (MS3). Manual examina-
tion of the MS3 spectrum (Figure 2c) showed a domi-
nant peak at m/z 325, corresponding to a neutral loss of
116 Da from the ion-molecule reaction product. This losscorresponds to the molecule HOB(N(CH3)3)2, which is
indicative of an aliphatic tertiary N-oxide (Figure 1).
Similar results were obtained when this methodology
was applied to mixtures of the antipsychotic drug
olanzapine and the antihistamine loratadine with their
N-oxide derivatives. It should be noted here that these
experiments have the same duty cycle as the traditional
MS3 experiments based on CAD alone, with about 3–5
MS3 spectra acquired per HPLC peak.
Data-Dependent Neutral Gain Pseudo-MS3
Pseudo-MS3 experiments were performed to determine
whether the duty cycle of the data-dependent MS3
experiment could be decreased. Conversion of the MS3
Figure 2. (a) Mass spectrum obtained for clozapine N-oxide after
positive mode ESI. (b) MS2 spectrum obtained for clozapine
N-oxide after isolation of the protonated molecule (m/z 343) and
exposure to TDMAB for 30 ms. The observed neutral gain of 98 Da
(m/z 441) corresponds to formation of the expected ion-molecule
reaction product and indicates the presence of an N-oxide. (c) MS3
spectrum obtained after CAD of the TDMAB derivatization prod-
uct of clozapine N-oxide (m/z 441). The neutral loss of 116 Da,
corresponding to loss of HOB(N(CH3)2)2, indicated by the ion of
m/z 325 is characteristic for tertiary aliphatic N-oxides.experiment into a MS2 experiment (pseudo-MS3) was
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of the MS2 and MS3 spectra. Applying this technique to
the analyses described above requires judicious choice
of the activation energy and, in some cases, the activa-
tion q value. The activation energy must be chosen such
that the protonated analyte undergoes minimal frag-
mentation, but the ion-molecule reaction product still
fragments, since the same normalized collision energy
is used for both experiments due to software limita-
tions. The activation q value is an important factor
when analyzing tertiary aromatic N-oxides, since the
characteristic fragment ion of m/z 115 may be near or
below the low-mass cutoff for the isolated analyte.
The pseudo-MS3 spectra acquired for an artificial
mixture of the hydroxyl and N-oxide metabolites of
loratadine (1 g/mL of each analyte) are shown in
Figure 3. The experiment was performed using a nor-
malized collision energy of 10% and a q value of 0.15 for
CAD. Both spectra display the ion-molecule reaction
product of m/z 497 and an abundant fragment ion of m/z
353, which is the dominant fragment ion for both proton-
ated molecules upon CAD. However, expansion of the
low mass region of these mass spectra allows the differ-
entiation of the two isomers. The TDMAB-derivatized
3-hydroxyloratadine does not display any functional
group-specific fragmentation, while TDMAB-derivatized
loratadine N-oxide produces the fragment ion of m/z 115
that is characteristic of aromatic N-oxides (Figure 1). By
using the pseudo-MS3 approach, the number of spectra
Figure 3. Pseudo-MS3 spectra obtained by isolating the proton-
ated analyte (m/z 399) of (a) 3-hydroxyloratadine and (b) lorata-
dine N-oxide, followed by exposure to TDMAB (q value 0.15;
normalized collision energy 10%). Following this step, the ion-
molecule reaction product (m/z 497) was subjected to CAD (nor-
malized collision energy 10%) in the presence of all ions in the trap
(i.e., without isolation). Inspection of the mass spectra reveals that
only the derivatized aromatic N-oxide displays the characteristic
fragment ion of m/z 115.that could be acquired per HPLC peak increased up to
about 8.
Conclusions
The combination of data-dependent acquisition with
LC/MS3 based on ion-molecule reactions and CAD
increases the throughput of N-oxide metabolite charac-
terization by allowing for automated functional group
identification. Although this methodology was specifi-
cally demonstrated for the N-oxide functional group, it
can be applied to other metabolites via judicious choice
of the neutral reagent (i.e., by choosing neutral reagents
specific to other functional groups). Since these experi-
ments facilitate the identification of specific biotransfor-
mations “on-the-fly,” they allow for quick and efficient
determination of metabolic “hot spots” during drug
discovery. This type of an analytical method is readily
implemented by using commercial software platforms,
though careful attention must be paid to certain exper-
imental parameters. The results obtained using pseudo-
MS3 experiments (i.e., combining MS2 and MS3) on the
LQIT provides the impetus for adapting these methods
to triple quadrupole instruments. These experiments
are currently underway in our laboratories.
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